Your browser doesn't support javascript.
loading
CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised, open-label, multicentre, phase 3 trial.
Lancet, Jeffrey E; Uy, Geoffrey L; Newell, Laura F; Lin, Tara L; Ritchie, Ellen K; Stuart, Robert K; Strickland, Stephen A; Hogge, Donna; Solomon, Scott R; Bixby, Dale L; Kolitz, Jonathan E; Schiller, Gary J; Wieduwilt, Matthew J; Ryan, Daniel H; Faderl, Stefan; Cortes, Jorge E.
Afiliación
  • Lancet JE; H Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Electronic address: jeffrey.lancet@moffitt.org.
  • Uy GL; Washington University School of Medicine, St Louis, MO, USA.
  • Newell LF; Knight Cancer Institute, Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR, USA.
  • Lin TL; University of Kansas Medical Center, Kansas City, KS, USA.
  • Ritchie EK; Weill Cornell Medical College of Cornell University, New York, NY, USA.
  • Stuart RK; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
  • Strickland SA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Hogge D; Leukemia/Bone Marrow Transplant Program of British Columbia, Vancouver, BC, Canada.
  • Solomon SR; Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA, USA.
  • Bixby DL; Comprehensive Cancer Center, University of Michigan, Grass Lake, MI, USA.
  • Kolitz JE; Monter Cancer Institute, Northwell Health System, Lake Success, NY, USA.
  • Schiller GJ; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Wieduwilt MJ; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK, USA.
  • Ryan DH; University of Rochester, Rochester, NY, USA.
  • Faderl S; Jazz Pharmaceuticals, Palo Alto, CA, USA.
  • Cortes JE; University of Texas MD Anderson Cancer Center, Houston, TX, USA; Georgia Cancer Center, Augusta University, Augusta, GA, USA.
Lancet Haematol ; 8(7): e481-e491, 2021 Jul.
Article en En | MEDLINE | ID: mdl-34171279
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_leukemia Asunto principal: Leucemia Mieloide Aguda / Daunorrubicina / Citarabina Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_leukemia Asunto principal: Leucemia Mieloide Aguda / Daunorrubicina / Citarabina Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Año: 2021 Tipo del documento: Article